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ABSTRACT
FEN-1 and XPG are members of the FEN-1 family of
structure-specific nucleases, which share a con-
served active site. FEN-1 plays a central role in DNA
replication, whereas XPG is involved in nucleotide
excision repair (NER). Both FEN-1 and XPG are
active on flap structures, but only XPG cleaves
bubble substrates. The spacer region of XPG is
dispensable for nuclease activity on flap substrates
but is required for NER activity and for efficient
processing of bubble substrates. Here, we inserted
the spacer region of XPG between the nuclease
domains of FEN-1 to test whether this domain
would be sufficient to confer XPG-like substrate
specificity and NER activity on a related nuclease.
The resulting FEN-1-XPG hybrid protein is active on
flap and, albeit at low levels, on bubble substrates.
Like FEN-1, the activity of FEN-1-XPG was stimu-
lated by a double-flap substrate containing a 1-nt 30
flap, whereas XPG does not show this substrate
preference. Although no NER activity was detected
in vitro, the FEN-1-XPG hybrid displays substantial
NER activity in vivo. Hence, insertion of the XPG
spacer region into FEN-1 results in a hybrid protein
with biochemical properties reminiscent of both
nucleases, including partial NER activity.
INTRODUCTION
FEN-1 and XPG belong to the FEN-1 family of structure-
speciﬁc nucleases, the members of which fulﬁll diverse
biological roles and cleave branched DNA structures with
conserved polarity at the junction of single-stranded (ss)
and duplex (ds) DNA (1). FEN-1 has an essential role in
DNA replication in the processing of Okazaki fragments
and has additional functions in base excision repair and in
other pathways contributing to the maintenance of
genome stability (2,3). XPG plays a central role in
nucleotide excision repair (NER) where it makes the
incision on the 30 side of the DNA lesion (4–8). XPG also
fulﬁlls a structural role in the assembly of NER complexes
since its presence, but not its catalytic activity, is required
for the 50 incision by ERCC1-XPF (9–11). Consistent with
the contribution of FEN-1 and XPG to diﬀerent DNA
repair and replication pathways, they show similar but
distinct substrate speciﬁcities in vitro. XPG shows
structure-speciﬁc properties cleaving artiﬁcial DNA
structures that contain ss/ds DNA junctions, including
bubbles and splayed arm substrates with the same polarity
as in the NER reaction (7,12,13). In contrast, FEN-1 only
acts on substrates that have free 50 ss DNA ends and does
not process DNA bubble structures or loops that are
substrates for XPG (14,15). In addition, the nuclease
activity of FEN-1 is greatly increased on a double-ﬂap
structure containing a 1-nt 30 ﬂap adjacent to the 50 ﬂap
compared to the conventional 50 ﬂap substrate (16,17).
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Such double-ﬂap structures might be the real in vivo
substrates for FEN-1 during replication (18).
Members of the FEN-1 family of nucleases have a
conserved nuclease core composed of the N-terminal (N-)
and internal (I-) regions (1). Crystal structures of FEN-1
family proteins from diﬀerent species revealed that the N-
and I- regions form a conserved globular domain contain-
ing the active site (19–22). In most FEN-1 family
members, the N- and I- regions are separated by 570
amino acids. This region forms a helical arch that is
located above the active site and plays a role in DNA
binding and catalysis (23). In addition, FEN-1 contains a
small surface-exposed hydrophobic wedge and a 1-nt-
binding pocket, which provides speciﬁcity for double-ﬂap
structures and appears to contribute to the positioning of
the ssDNA 50 ﬂap near the active site (24,25).
XPG diﬀers from the other FEN-1 family members in
that the N- and I- regions are separated by a stretch of over
600 amino acids designated ‘spacer region’, which shows
no homology to other known proteins or motifs (26).
An obvious role for this spacer region would be in
conferring the substrate speciﬁcity and mediating pro-
tein–protein interactions required for NER. Indeed, some
parts of the spacer region interact with the XPB, XPD, p62
and p44 subunits of the transcription/repair factor TFIIH
(27) and perhaps also with RPA (28). The interaction
between TFIIH and XPG is of particular relevance since
TFIIH needs to be present at sites of DNA damage for the
recruitment of XPG following the initial damage recogni-
tion by XPC-HR23B (29–31). To address the role of the
XPG spacer region, we have generated several mutants
of XPG in a previous study and showed that deletions in
the spacer region can result in loss of NER activity and
defective interaction with TFIIH (32,33). Furthermore, the
spacer region of XPG contributes to the substrate
speciﬁcity of XPG as it is required for eﬃcient bubble
cleavage activity. These results demonstrate that the
spacer region is, to a signiﬁcant degree, responsible for
the NER-speciﬁc functions of XPG.
In the present study, we tested whether the spacer
region is suﬃcient for mediating NER-speciﬁc function of
XPG or whether additional parts of the protein con-
tribute. For this purpose, we inserted the XPG spacer
region between the N- and I- regions of the FEN-1 protein
and investigated the biochemical and cell biological
properties of this FEN-1-XPG hybrid protein. Our studies
reveal that FEN-1-XPG displays speciﬁcities on model
substrates reminiscent of both XPG and FEN-1, demon-
strating that it is a gain of function modiﬁcation with
respect to both XPG and FEN-1. FEN-1-XPG displayed
partial NER activity in vivo, showing that the insertion of
the XPG spacer region in the FEN-1 backbone allows the
hybrid protein to carry out NER-related functions.
MATERIALS AND METHODS
Construction of FEN-1-XPG hybrid mutant
To construct FEN-1-XPG, FEN-1 DNA sequence from
nucleotide 1 to 315 (fragment I) was ampliﬁed by PCR
using the primer (50-AATTCAATCAGCGGCCGCAT
GGGAATTCAAGGCCTGGC) and (50-AATTCAA
AGCTTCCGCCGCTCACTGCGTTTG) and the plas-
mid pET28a-FEN-1 as template. The primers incorpo-
rated a NotI restriction site 50 of the FEN-1 ORF and a
HindIII restriction site 30 of the PCR fragment. Primers
(50-AATTCAATCAATTAATGCTGAGGCAGAGAAG
CAGG) and (50-AATTCAGGTACCTTAATGATGGTG
GTGATGGTGTTTTCCCCTTTTAAACTTCCC) were
used to amplify the FEN-1 sequence from nucleotide 316
to 1143 (fragment II), introducing a 50 AseI restriction site,
a His6 tag and the stop codon followed by a KpnI
restriction site at the 30 end. pFastBac1-XPG (13) was
digested with NotI and AseI, and the 2.2 kb NotI-AseI
XPG fragment was ligated together with the AseI-KpnI
digested FEN-1 fragment II and the NotI-KpnI digested
pFastBac1 vector in a three-point ligation. The NotI-
HindIII digested FEN-1 fragment I was ligated into the
NotI-HindIII digested pFastBac1 vector.
For transduction of XP-G/CS ﬁbroblasts, FEN-1-XPG
(in pFastBac1) and FEN-1 (in pET28a) cDNA constructs
were cloned into the pLOX/EWgfp lentiviral vector by
replacing the GFP cDNA (32).
XPG, FEN-1 and FEN-1-XPG hybrid proteins expression
and purification
XPG and FEN-1-XPG were expressed in Sf9 insect cells
and puriﬁed as described previously (13), with minor
modiﬁcations. The majority of XPG and FEN-1-XPG
eluted from the nickel beads at 100mM imidazole. XPG
eluted from the HiTrap S column between 400 and
600mM NaCl and FEN-1-XPG between 350 and 500mM
NaCl. From the HiTrap Q column, XPG eluted between
450 and 600mM NaCl and FEN-1-XPG between 500 and
650mM NaCl. Protein concentrations were determined
using the Bradford protein assay with BSA as a standard.
Concentrations between 0.1 and 0.3mg/ml of puriﬁed
proteins were obtained with an overall yield of 0.2-0.5mg.
Human FEN-1 cDNA was ampliﬁed by PCR from
HeLa RNA ﬁrst-strand cDNA synthesis (Clontech),
equipped with a C-terminal His6 tag and cloned into
pET28a using NcoI and XhoI restriction sites.
The plasmid was transformed into the Rosetta pLysS
strain (Novagen) and grown at 378C to an OD600 nm of 0.6
and induced with 1mM IPTG for 4–5 h at 378C. The cells
were lysed by sonication in buﬀer A (500mM NaCl,
20mM Hepes pH 8, 10% glycerol, 2mM b-mercapto-
ethanol, 0.1% NP-40) and batch puriﬁed over Ni-NTA
Sepharose using buﬀer Aþ 2mM imidazole for loading
and eluted with buﬀer Aþ 60mM imidazole. Fractions
containing FEN-1 were dialyzed against buﬀer Z (20mM
Hepes pH 8, 10% glycerol, 2mM DTT, 1mM
EDTA)þ 50mM KCl and puriﬁed on a S Sepharose
column using a gradient of 50mM to 1M KCl. FEN-1
eluted as a sharp peak at around 400mM KCl.
DNA binding and cleavage and in vitroNER assays
Oligonucleotides described previously (see Table 1 in (13))
were used to generate the splayed arm (oligonucleotide A20
and B19), ﬂap (oligonucleotide A20, B19 and C19) and
bubble substrates. DNA cleavage and binding assays were
3054 Nucleic Acids Research, 2007, Vol. 35, No. 9
performed as described previously (13). To construct the
double-ﬂap substrate containing a 1-nt 30 ﬂap, oligonucleo-
tide C20 that contains one additional A nucleotide at the 3
0
end was used instead of oligonucleotide C19. Substrates
were annealed with a 2-fold excess of the unlabeled
oligonucleotide(s). In DNA cleavage assays, the reaction
was activated by addition of 0.5mM MnCl2 for XPG and
1mM MnCl2 for FEN-1 and FEN-1-XPG. Cleavage
assays were analyzed by denaturing and binding assays
by native PAGE. Each gel was quantiﬁed using a Typhoon
9400 PhosphorImager (Amersham Biosciences) and Image
Quant version 5.2 software from Molecular Dynamics. In
all studies, the amount of substrate and product was
quantiﬁed, and the percentage of substrate cleavage was
determined by the product/(substrateþproduct) ratio. This
method allows for correction of any loading errors among
lanes. All assays were performed at least in duplicate, and
representative gels are shown.
For the in vitro NER assay, a 24-mer oligonucleotide
containing a unique GTG sequence (50-TCTTCTT
CTGTGCACTCTTCTTCT) was platinated to produce
a 1,3-intrastrand GpTpG-crosslink. This oligonucleotide
was used in primer extension reaction with ssDNA of
pBluescript KS as a template, and puriﬁed as described
previously (34). The NER assay was performed as
described previously (32).
Cell culture conditions, preparation of whole-cell extracts and
transduction with lentiviral recombinants
For the generation of whole-cell extracts, SV40 trans-
formed ﬁbroblasts XPCS1RO (35) were cultured in
Modiﬁed Eagle’s Medium (MEM) (Gibco) supplemented
with 10% fetal calf serum (FCS) and 2mM L-glutamine,
100U/ml penicillin and 100mg/ml streptomycin at 378C in
the presence of 5% CO2. Cells were grown to near
conﬂuency, and whole-cell extract was prepared according
to a published procedure (36).
For the transduction experiments, primary ﬁbroblasts
from a severely aﬀected XP-G/CS patient (XP20BE)
(37,38) were cultured in MEM supplemented with
15% FCS, 2mM L-glutamine, 100U/ml penicillin and
0.1mg/ml streptomycin. Cells were grown in a 5% CO2
humidiﬁed incubator. 293T cells were cultured in
Dubelcco Modiﬁed Eagles Medium (DMEM) supplemen-
ted with 10% FCS, 2mM L-glutamine, 100U/ml peni-
cillin and 0.1mg/ml streptomycin and kept in a 5% CO2
humidiﬁed incubator. Recombinant lentiviruses contain-
ing the XPG, FEN-1-XPG and FEN-1 cDNAs under the
control of the EF1a promoter were produced as described
previously (32). Infection was carried out by adding the
viral particles containing the diﬀerent recombinants to
XP-G/CS primary ﬁbroblasts (XP20BE) at 50% con-
ﬂuency. Fibroblasts were then cultured normally for
various times, and the transduction eﬃciency was assessed
by immunoﬂuorescence and western blotting.
Survival assay and detection of 6-4 photoproducts by
immunodot blot analysis
Cells were irradiated as described previously (32), and
viability was assessed 72 h post-irradiation using the
CellTiter 96 AQueous One Solution Cell Proliferation
Assay (Promega) according to the manufacturer’s instruc-
tions. The number of proliferating cells was measured by
recording the absorbance at 490 nm with a 96-well plate
reader (Bio-Rad). Viability assays were performed inde-
pendently four times using three independent sets of
transduced cells. For immunodot blots, cells were
irradiated with a UVC dose of 20 J/m2 and pelleted at
diﬀerent times post-UV. DNA was isolated using the
Puregene method (Gentra systems) according to the
manufacturer’s instructions. Immunodot blots were per-
formed as previously described (39) using 64M-2 anti-
bodies against 6-4PPs (gift from O. Nikaido).
Local UV irradiation and immunofluorescence
Local UV irradiation and immunoﬂuorescence were
performed as described previously (32) with the following
modiﬁcations. The primary antibodies, mouse monoclonal
anti-XPG (clone 1G12, gift from J.M. Egly) at 1/1000
dilution and rabbit polyclonal anti-p89 at 1/600, were
added for 1 h at room temperature in 1 PBS containing
1% BSA. Detection of 6-4PPs was performed as described
previously. Transduced cells were analyzed for the
presence/absence of foci, and untransduced cells were
used as negative control. Stained cells were observed in a
Zeiss Axiocam microscope using the Axiovision software.
RESULTS
Construction and purification of FEN-1-XPG hybrid protein
In a previous study, we have shown that the deletion of the
spacer region in XPG resulted in a defect in NER and in
reduced bubble cleavage activity (32). We wanted to test
whether the spacer region is suﬃcient to mediate these
XPG-speciﬁc functions and reasoned that the insertion of
the 600 amino acid spacer region of XPG into the
homologous FEN-1 protein would be a suitable experi-
mental approach to test this notion. FEN-1 shares a
conserved nuclease domain (N- and I- regions) with XPG,
but its N- and I- regions are separated by only about
70 amino acids, deﬁned as a helical clamp structural motif.
Based on FEN-1 crystal structures (21,22), we hypothe-
sized that the insertion of XPG spacer into FEN-1
between amino acid residue 104 and 105, in an unstruc-
tured region just N-terminal to a helix 4, should not
dramatically alter the structure of the FEN-1 nuclease
active site. We incorporated new HindIII and AseI
restriction sites into FEN-1 by PCR and inserted the
XPG DNA fragment corresponding to the XPG spacer
region from amino acid residue 108 to 732 (Figure 1A), as
described in the ‘Materials and methods’ section. We refer
to this hybrid protein as FEN-1-XPG.
XPG and FEN-1-XPG protein with a C-terminal his
tag were expressed in Sf9 insect cells and puriﬁed as
described previously (13) (Figure 1B). The FEN-1-XPG
protein of 1005 amino acids was soluble and presented
similar elution proﬁles to XPG during protein puriﬁca-
tion, indicating that the hybrid protein is properly folded.
Since the spacer region of XPG is very acidic (pI 4.5), its
insertion into FEN-1 yielded a hybrid protein with
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signiﬁcantly lower pI of 4.9 compared to FEN-1 (pI of
8.8). As observed for XPG, the FEN-1-XPG hybrid
protein of 112 kDa migrated above its molecular weight
on SDS-PAGE (Figure 1B), providing further evidence
that the low pI of the spacer region is responsible for the
abnormal migration behavior of XPG (32).
FEN-1-XPG exhibits endonuclease activity on flap and
bubble substrates
We ﬁrst wanted to examine whether the insertion of the
600 amino acids spacer of XPG into FEN-1 protein has
any eﬀect on the proper folding of the FEN-1 nuclease
domain. We performed nuclease assays with increasing
concentrations of puriﬁed XPG, FEN-1-XPG and FEN-1
on a ﬂap substrate, which is processed by both XPG and
FEN-1 (12,40). FEN-1-XPG showed comparable activity
to XPG on the ﬂap substrate in the presence of either
Mg2þ or Mn2þ (Figure 2A, compare top and middle
panel, Figure 2C, left panel and data not shown).
This result conﬁrms that the insertion of the 600 amino
acid spacer region into FEN-1 does not interfere with the
proper folding of the nuclease domain. However, the
hybrid protein showed somewhat reduced nuclease
activity compared to FEN-1 (Figure 2A, compare
middle and bottom panel; Figure 2C, left panel). It has
been previously shown that the ﬂexible loop between the
nuclease domains in FEN-1 assumes an ordered con-
formation upon substrate binding, which might be
important for eﬃcient cleavage by properly positioning
the substrate (22,41). It is likely that the insertion of the
spacer region in the ﬂexible loop interferes with a
structural rearrangement, resulting in reduced activity of
FEN-1-XPG compared to FEN-1.
XPG exhibits nuclease activity on bubble substrates,
while FEN-1 is unable to cleave such substrates (14,15,40).
Since the XPG spacer region was shown to be essential for
Figure 1. Construction and puriﬁcation of FEN-1-XPG hybrid protein.
(A) Schematic representation of XPG, FEN-1 and FEN-1-XPG hybrid
proteins. The conserved N- and I- nuclease regions are indicated.
The HindIII and AseI restrictions sites were incorporated by site-
directed mutagenesis into FEN-1 at amino acids position 104/105.
These sites were used to insert the HindIII-AseI fragment of the XPG
spacer (residues 108 to 732) into FEN-1 to generate the FEN-1-XPG
hybrid. The amino acid sequences at the cloning sites are shown. The
number of amino acids (aa), the molecular weight (Mw) and the
isoelectric point (pI) values of the proteins are indicated. (B) XPG and
FEN-1-XPG were expressed and puriﬁed from Sf9 insect cells, and
FEN-1 was puriﬁed from Escherichia coli as described in the ‘Materials
and methods’ section. Puriﬁed proteins were analyzed on an 8% SDS-
polyacrylamide gel. Lane 1, broad range marker (1mg of protein/band);
molecular weights are indicated. Lane 2–4, 2 mg of XPG, FEN-1-XPG
and FEN-1 proteins, respectively.
Figure 2. Endonuclease activity of FEN-1-XPG hybrid protein on ﬂap
and bubble substrates. (A) Puriﬁed proteins were incubated for 45min
at 308C with 2.5 nM of ﬂap substrate (lanes 1–8) in the presence
of 0.5mM MnCl2 for XPG and 1mM MnCl2 for FEN-1-XPG and
FEN-1. The following protein concentrations were used: 0 nM (lane 1),
0.5 nM (lane 2), 1 nM (lane 3), 2 nM (lane 4), 4 nM (lane 5), 8 nM
(lane 6), 20 nM (lane 7) and 40 nM (lane 8). The position of the 5032P
label on the substrate is indicated by the asterisk. The length of the
products was determined by comparison with an authentic standard
and is indicated. (B) Incision activity of puriﬁed proteins on the bubble
substrate using the conditions described in A. (C) Cleavage eﬃciency of
XPG, FEN-1 and FEN-1-XPG on the ﬂap substrate (left) and bubble
substrate (right) with increasing protein concentration. Graphs repre-
sent the quantiﬁcation of two independent experiments. Standard
deviations are represented by error bars.
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eﬃcient bubble cleavage activity (32), we tested whether
FEN-1-XPG displayed bubble cleavage activity.
As expected, XPG eﬃciently cleaved the bubble substrate,
whereas FEN-1 did not (Figure 2B, top and bottom panel,
Figure 2C, right panel). FEN-1-XPG showed signiﬁcant
activity on the bubble compared to FEN-1 (Figure 2B,
compare middle and bottom panels), albeit at much lower
levels than XPG (Figure 2B, top panel). FEN-1-XPG
cleavage activity reached a plateau at 10% conversion
(Figure 2C, right panel), and longer incubation times did
not lead to signiﬁcantly higher activity (data not shown).
The failure of FEN-1 and the low activity of FEN-1-
XPG to cleave the bubble substrate were not caused by a
reduction in DNA substrate binding. Electrophoretic
mobility shift assays revealed no signiﬁcant diﬀerences in
the binding eﬃciencies of XPG, FEN-1-XPG and FEN-1
to a bubble substrate in the presence of a 50-fold excess of
cold duplex competitor DNA, demonstrating speciﬁc
binding to ss/dsDNA junctions (Figure 3).
FEN-1 and FEN-1-XPG but not XPG show a preference for
double-flap substrates
FEN-1 was shown to exhibit higher nuclease activity on a
double-ﬂap substrate with a 1-nt 30 ﬂap overhang in
addition to the 50 ﬂap due to higher substrate-binding
activity (16,17,42). Structural studies revealed a speciﬁc
1-nt-binding pocket in the N-region explaining this
preference for the 30 ﬂap (24). We compared the cleavage
activity of XPG, FEN-1-XPG and FEN-1 on a double-
ﬂap substrate with a 1-nt 30 ﬂap. XPG showed
equal activity on the single- and double-ﬂap substrates
(Figure 4A, compare lanes 2-7 and 9-14), whereas FEN-1
had higher nuclease activity on the double ﬂap substrate
(Figure 4C, compare lanes 2-7 and 9-14). Like FEN-1, the
cleavage activity of FEN-1-XPG was strongly stimulated
by the presence of the 1-nt 30 ﬂap (Figure 4B, compare
lanes 2-7 and 9-14). Although the overall activity of FEN-
1-XPG was lower than that of FEN-1, the degree of
stimulation of a double-ﬂap compared to a single-ﬂap
substrate was similar for both proteins (Figure 4C).
This suggests that the insertion of the spacer region of
XPG into the helical loop of FEN-1 has no inﬂuence on
the structure of the 30 1-nt ﬂap binding pocket. Consistent
with this observed preference for cleaving double-ﬂap
substrates, FEN-1 and FEN-1-XPG, but not XPG,
showed increased binding activity for the double-ﬂap
compared to the single-ﬂap substrate (Figure 5).
FEN-1-XPG has partial NER activity in vivo
The spacer region of XPG is necessary to mediate protein–
protein interactions required for NER (32). We wondered
whether the spacer region would be suﬃcient for NER
activity characteristic of XPG when imbedded in a
diﬀerent structure-speciﬁc nuclease. We ﬁrst tested
whether the FEN-1-XPG hybrid protein could perform
the incision 30 to the lesion in an in vitro NER assay.
We monitored the excision of a 24–32 mer oligonucleotide
from a plasmid containing a site-speciﬁc 1,3 cisplatin
adduct using an extract from a repair-deﬁcient XP-G/CS
ﬁbroblast cell line supplemented with recombinant pro-
teins. As expected, the formation of NER excision
products was observed upon addition of puriﬁed XPG.
In contrast, no excision products were detected in the
reactions containing FEN-1-XPG or FEN-1 (Figure 6),
even at elevated protein concentrations (data not shown).
These results suggest that the spacer region of XPG
embedded in FEN-1 is not suﬃcient to support NER
incision activity under the conditions used in our in vitro
assays.
We then tested whether the FEN-1-XPG protein was
able to correct the UV sensitivity of XPG-deﬁcient cells.
We had previously observed that the amount of UV
resistance conferred by mutant XPG proteins to XP-G/CS
cells was a more sensitive measure of NER activity than
the in vitro NER assays (32). Primary XP-G/CS
ﬁbroblasts (XP20BE) were, therefore, transduced with
lentiviral recombinants containing XPG, FEN-1 or FEN-
1-XPG. Transduced cells were irradiated with increasing
UV doses (0–6 J/m2), and cell viability was measured using
a colorimetric assay at 72 h post treatment. Untransduced
XP-G/CS cells lacking a functional XPG protein showed a
strong sensitivity to UV irradiation (Figure 7A). Similar
UV sensitivity was observed when cells were transduced
with a lentivirus containing the GFP gene (data not
shown). In contrast, when XP-G/CS cells were transduced
with XPG, they became resistant to UV irradiation, and
more than 80% of these cells survived a UV dose of 6 J/m2
(Figure 7A). Surprisingly, we observed an intermediate
resistance to UV of transductants expressing FEN-1-XPG
(Figure 7A). Although no NER activity in vitro was
observed for FEN-1-XPG, it seems that these cells still
retain some repair activity in vivo and are able to confer
some UV resistance. This is not due to an unanticipa-
ted activity of FEN-1 because control transductants
Figure 3. DNA binding of XPG, FEN1-XPG hybrid and FEN1
proteins to bubble substrates. DNA binding was analyzed using
electrophoretic mobility shift assays. Radiolabeled bubble substrate
(2.5 nM) was incubated in nuclease buﬀer A for 15min in the presence
of a 50-fold excess of cold dsDNA competitor in the absence of
divalent metal ions with increasing concentrations of XPG (lanes 2–5),
FEN1-XPG (lanes 7–10), FEN-1 (lanes 12–15) or no protein (lanes 1, 6
and 11). The following protein concentrations were used: 10 nM (lanes
2, 7 and 12), 15 nM (lanes 3, 8 and 13), 20 nM (lanes 4, 9 and 14) and
25 nM (lanes 5, 10 and 15). Bound substrates (bs) were separated from
the free or unbound substrate (fs) on a 5% native polyacrylamide gel.
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expressing only FEN-1 were as highly sensitive to UV as
untransduced XP-G/CS cells (Figure 7A).
To more directly assay DNA repair, we monitored the
disappearance of 6-4PPs over time by immunodot blot
analysis. XPG, FEN-1-XPG or FEN-1 transductants were
exposed to a UV dose of 20 J/m2, and genomic DNA was
isolated at various times thereafter. The DNA samples
were then probed with monoclonal antibodies against the
6-4PPs (43,44). The disappearance of the signals for
6-4PPs over time indicates proper removal of these lesions
by NER. As expected for NER-deﬁcient cells, the signals
for 6-4PPs persisted up to 48 h post-UV in untransduced
XP-G/CS cells (Figure 7B, lane 1, and data not shown).
In contrast, these damages were rapidly repaired in XP-
G/CS cells expressing XPG (Figure 7B, lane 2). Only
background levels of the signal were observed 2–4 h post-
UV in XPG/CS cells expressing XPG (Figure 7B, lane 2),
indicating that the presence of functional XPG protein
renders these cells NER proﬁcient. In transductants
expressing FEN-1-XPG, the 6-4PPs signal levels started
to decrease at 8 h post-UV and almost disappeared after
24 h (Figure 7B, lane 3). The disappearance of the 6-4PP
signal in these transductants suggests that they possess a
signiﬁcantly increased repair activity compared to
untransduced XP-G/CS cells. In contrast, no repair of
the 6-4PPs was observed in XP-G/CS cells transduced
with FEN-1 (Figure 7B, lane 4). These results are fully
consistent with the in vivo survival curves (Figure 7A).
Together, they suggest that the presence of the XPG
spacer region in the FEN-1 backbone modiﬁes FEN-1
nuclease activity to permit the cleavage of UV lesions with
signiﬁcant eﬃciency, thereby conferring intermediate UV
resistance to the FEN-1-XPG transductants.
The FEN-1-XPG hybrid protein is not visible at sites of UV
damage
The kinetics of the NER reaction and the assembly and
disassembly of the proteins involved at sites of UV
damage can be monitored by local irradiation of
individual cells and staining of cells at various time
points after that using antibodies against UV-damaged
DNA or NER proteins (29,45). We have previously used
this technique to show that an intact spacer region in XPG
is required for the eﬃcient recruitment of the protein to
the sites of UV damage (32). Here, we asked whether the
presence of the XPG spacer region in the FEN-1 protein
would be suﬃcient to allow the recruitment of the hybrid
Figure 4. Endonuclease activity of XPG, FEN-1 and FEN-1-XPG on a single- and double-ﬂap substrate. The endonuclease activity of XPG (A),
FEN-1-XPG (B) and FEN-1 (C) was assessed on a single 50 ﬂap substrate (lanes 1–7) or on a double-ﬂap substrate with an additional 1-nt 30 ﬂap
(lanes 8–14). 2.5 nM of substrate was incubated for 40min at 308C in the presence of 0.5mM MnCl2 for XPG or 1mM MnCl2 for FEN-1-XPG and
FEN-1. The diﬀerent protein concentrations for XPG, FEN1-XPG and FEN-1 are indicated (in nM) on the top of each gel. The position of the 5032P
label on the substrate is indicated by the asterisk. The length of the products was determined by comparison with authentic standards and is
indicated. The percentage of substrate cleavage versus protein concentration is presented graphically (right panels) for each protein. Graphs show the
quantiﬁcation of two independent experiments. Standard deviations are indicated by error bars.
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protein to sites of UV damage. XP-G/CS transductants
expressing XPG or FEN-1-XPG were irradiated with
150 J/m2 through an 8 mm pore ﬁlter. Cells were then ﬁxed
30min and 24 h post-UV, and the XPG and XPB proteins
as well as the 6-4PPs were detected with appropriate
antibodies. As shown previously (32), untransduced
XP-G/CS cells contain no detectable XPG protein, but
the XPB subunit of TFIIH colocalizes with 6-4PPs 30min
post-UV independently of XPG (Figure 8, 30min post-
UV, Untransduced), and these XPB/6-4PPs foci persist for
over 24 h (Figure 8, 24 h post-UV, XPB/6-4PPs). Hence,
XPG is not needed for the earliest damage recognition
events but it is required for damage resolution. In XP-G/
CS transductants expressing wild-type XPG, this protein
was present in nuclear foci at the UV lesions and
colocalized with the XPB and 6-4PPs 30min post-UV
(Figure 8, 30min post-UV, XPG). By 24 h post-UV, foci
for XPG, XPB and 6-4PPs have all disappeared, indicat-
ing that repair had been completed (Figure 8, 24 h post-
UV, XPG).
In the hybrid transductants, FEN-1-XPG protein was
not detectable in foci that contained XPB and 6-4PPs
30min post-UV (Figure 8, 30min post-UV, FEN-1-XPG).
However, the XPB/6-4PP foci had disappeared by 24 h
post-UV, indicating that NER had been completed in
these cells (Figure 8, 24 h post-UV, FEN-1-XPG). We had
previously observed similar results for certain XPG
mutants with deletions in the spacer region (32). This
behavior of XP-G/CS cells expressing the FEN1-XPG
hybrid protein is consistent with the intermediate survival
and repair kinetics of these cells. As a possible mechanistic
explanation, the FEN-1-XPG protein may be recruited
less stably or with slower kinetics to NER repair
complexes.
DISCUSSION
In this study, we have generated a hybrid human protein
containing the nuclease domains of FEN-1 and the spacer
region of the XPG protein to ask if the spacer region of
XPG is suﬃcient to confer NER-speciﬁc functions to a
diﬀerent nuclease scaﬀold.
Biochemical activities of the FEN-1-XPG protein
The FEN-1-XPG protein displayed biochemical activities
that are characteristic of both XPG and FEN-1. Namely,
FEN1-XPG was able to cleave bubble substrates, which
Figure 5. Binding eﬃciencies of XPG, FEN1-XPG and FEN1 towards
a single- and a double-ﬂap substrate. DNA binding was analyzed using
electrophoretic mobility shift assays on the same substrates as used in
Figure 4. Either 2.5 nM single 50 ﬂap substrate (lanes 1–5) or double-
ﬂap substrate with a 1-nt 30 ﬂap (lanes 6–10) was incubated with
increasing protein concentrations of XPG (A), FEN-1-XPG (B) or
FEN-1 (C) in the absence of divalent metal ions in nuclease buﬀer A.
The protein concentrations used are indicated (in nM) on the top of
each gel.
Figure 6. FEN1-XPG does not restore NER activity in an XPG-
deﬁcient cell extract. Cell extracts prepared from XPCS1R0 ﬁbroblasts
were incubated with a plasmid containing a single 1, 3 cisplatin adduct
in absence of protein (lane 2) or in presence of 15 nM puriﬁed
recombinant XPG (lane 3), FEN1-XPG (lane 4) or FEN1 (lane 5).
The excision products containing the cisplatin adduct were labeled by
the annealing of an oligonucleotide complementary to the excised
oligonucleotides with a 50 GGGG overhang and ﬁlling in with
a-32PdCTP and Sequenase enzyme. The products were separated on a
14% denaturing polyacrylamide gel and visualized by autoradiography.
A MspI digest of pBR322 (lane 1) served as size marker.
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are not processed by FEN-1. At the same time, FEN-1-
XPG showed a preference for double-ﬂap over single-ﬂap
substrates, similar to FEN-1, while the activity of XPG
is equal for single or double ﬂaps. We found that the
preference for double ﬂaps was a result of increased
binding, consistent with the presence of a deﬁned
1-nt-binding pocket in FEN-1 revealed by structural
studies (24). Our studies suggest that this binding pocket
acts independently of the events surrounding catalysis.
The basis for the preferential cleavage of bubbles by XPG
and FEN-1-XPG over FEN-1 is less straightforward.
Our binding studies revealed that XPG and FEN-1-XPG
bind bubble substrates with comparable aﬃnities to FEN-
1. Similarly, we have previously shown that the change in
substrate speciﬁcity in XPG proteins with deletion in the
spacer region is not due to initial binding events (32).
We attempted to express the spacer region separately, but
were unable to obtain any soluble protein of that region
using a variety of conditions in the bacterial or
baculovirus expression systems (data not shown).
Furthermore, we were unable to detect this XPG fragment
in living cells by immunoﬂuorescence after transduction of
a lentiviral construct expressing the spacer region into
XPG/CS cells (data not shown). The predicted high degree
of disorder in that region is likely responsible for our
failure to analyze its properties directly. Although one
study has suggested a role for the spacer region in
substrate binding and recognition based on the inhibition
of the DNA-binding activity of XPG using a monoclonal
antibody directed against the spacer region (46), we
believe that a prominent role for the spacer region in the
catalytic step is most consistent with other available data.
For example, it has previously been found that the ﬂexible
loop between the nuclease domains in FEN-1 undergoes a
rearrangement to facilitate catalysis during the incision
reaction (22,41). The fact that FEN-1-XPG, in which this
ﬂexible loop has been disrupted by the introduction of the
XPG spacer region, shows reduced cleavage activity of
ﬂap substrates compared to FEN-1 supports an important
role of this loop in catalysis. Our studies suggest that this
rearrangement occurs subsequent to initial binding and
does not inﬂuence the binding aﬃnity. This mechanism of
initial binding and subsequent rearrangement to a
catalytically active conformation seems to be shared by
XPG, as we have previously demonstrated that it displays
distinct requirement for binding and catalysis (13).
The low level of bubble cleavage activity of FEN-1-
XPG indicates that additional regions of XPG contribute
to eﬃcient cleavage activity. Consistent with this, XPG
with a deletion in the spacer region showed reduced, but
substantial bubble cleavage activity (32). It is, therefore,
possible that the N- and I- regions of XPG make
Untransduced
XPG
FEN-1-XPG
XPG XPB
30 min post-UV
XPB/6-4PPs XPB/6-4PPsXPG XPB
24 hrs post-UV
Figure 8. Recruitment of FEN-1-XPG hybrid to local UV sites of damage in XP-G/CS cells. Cells were irradiated at 150 J/m2 through a ﬁlter with
8mm pores and ﬁxed 30min or 24 h after irradiation. Cells were then immunolabelled with antibodies against XPG (green), against the XPB subunit
of TFIIH (red) and against 6-4PPs (green). Merged images indicate the overlay of 6-4PPs and XPB staining. Scale bars, 10 mm.
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Figure 7. UV damage repair of XP-G/CS transductants expressing the
FEN-1-XPG hybrid. (A) UV survival curves of XP-G/CS cells
expressing XPG, FEN-1 and FEN-1-XPG proteins. XP-G/CS ﬁbro-
blasts (XP20BE) were transduced with the indicated cDNAs in
lentiviral recombinants and irradiated with the indicated doses of
UVC light. Their survival was monitored 72 h later by a colorimetric
assay. Each point represents the average of four independent
experiments. Error bars indicate the standard errors of the means.
(B) Levels of unrepaired UV DNA damage in XP-G/CS cells
transduced with XPG, FEN-1-XPG and FEN-1 cDNA. Cells were
irradiated with a UVC dose of 20 J/m2, and the subsequent retention of
6-4PPs was analyzed by immunodot blotting with antibodies against
6-4PPs. NI, non-irradiated.
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contributions to its unique substrate speciﬁcity that set it
apart from other FEN-1 family members. Alternatively,
the fact that the spacer region is slightly shortened in
FEN-1-XPG compared to XPG (it lacks 11 amino acids
immediately following the N-region and 33 amino acids
prior to the I-region) might limit its proﬁciency in cleaving
bubble substrates.
Recruitment ofXPGtoNERpreincision complexes byTFIIH
The recruitment of NER proteins to sites of repair can
readily be investigated using local UV irradiation of nuclei
of living cells through polycarbonate ﬁlters and subse-
quent detection of the lesions induced and NER proteins
recruited to them by immunohistochemistry (29,45,47).
We used this method to evaluate regions in XPG that
might contribute to the proper recruitment of the protein
to sites of NER. XPG is recruited within 30min following
irradiation, and it depends on the prior recruitment of
XPC/HR23B and TFIIH. Twenty-four hours after irra-
diation, NER proteins are no longer visible in foci,
indicating that repair has been completed (32,33).
Mutations in the spacer region of XPG can aﬀect
recruitment in two ways; in one case, XPG is recruited
to UV-damaged sites with normal kinetics, but is then
unable to properly execute its function in NER due to
unstable association with the preincision complex (33).
In the second case, the recruitment of XPG to UV-
damaged sites cannot be directly observed. However, since
the damage is ultimately repaired, albeit with slower
kinetics than in the wild-type situation, it can be inferred
that XPG was at some point present at the damaged site
(32). The fact that defects in the interaction with TFIIH
caused by diﬀerent mutations in XPG can inﬂuence the
recruitment of XPG as well as the subsequent processing
of NER substrates is a testimony to the complexity of the
interaction between the two proteins.
Several years ago, it was suggested that sequences
within and downstream of the I-region are also involved in
mediating the interaction with TFIIH and hence con-
tribute to the recruitment of XPG to sites of NER (27).
Indeed, in ongoing work, we have observed that replacing
the C-terminus of FEN-1 in FEN-1-XPG with the
C-terminus of XPG yielded a protein that displayed
wild-type levels of recruitment to sites of UV damage
(data not shown). While the ﬁrst generation design of this
hybrid protein containing the FEN-1 nuclease core and
spacer and C-terminal regions of XPG appeared not to
result in a fully functional protein and only restored UV
resistance to XP-G/CS cells at levels comparable to the
FEN-1-XPG protein, it provides evidence that two
independent regions in XPG are responsible for the
recruitment of the protein to NER preincision complexes
by interaction with TFIIH (27,29,30).
Multiple weak interaction sites facilitate progression through
the NER pathway
NER is a highly dynamic process that acts by sequential
assembly of the factors involved at the site of damage
(4,31,48). To ensure progression through the pathway, it is
advantageous to employ multiple weak interactions
between the proteins and DNA intermediates involved
rather than strong speciﬁc interactions such as those
employed by transcription factors binding to their DNA
substrates (49). The transient nature of many of the
interactions involved could serve as a basis for the NER
machinery to assemble dynamically and pass on substrates
from one subcomplex to the next. The modular structure
of the XPG protein and the modular nature of its
interaction with TFIIH and DNA ﬁt perfectly within
that paradigm. At least two regions of XPG, the spacer
region and the C-terminus, interact with the p44, p62,
XPD and XPB subunits of TFIIH (27). Recent studies
have shown that the ﬁrst 108 amino acids of the p62
subunit of TFIIH make up a pleckstrin homology and
phosphotyrosine binding (PH/PTB) domain that speciﬁ-
cally interacts with XPG (50). This PH/PTB domain is not
required for transcription or the integrity of TFIIH and
NMR studies showed that it forms a deﬁned 3D structure,
providing a ﬁrst glimpse of a modular domain involved in
the interaction between TFIIH and XPG. An important
future challenge will be to further determine the molecular
basis of the interaction of various modules of TFIIH
and XPG.
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